PR Newswire BiotechOriginal article
Acurx Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 14, 2026 Conference Call and Provide Business Update
EarningsNeutral
AI Analysis
Summary
Acurx Pharmaceuticals announced it will discuss second quarter 2026 financial results on August 14, 2026 and provide a business update regarding its antibiotic development program for difficult-to-treat bacterial infections.
Importance:2/10
Sentiment:
0.00
earningsconference callantibioticslate-stage
Related Companies
Read the original article
Published by PR Newswire Biotech on July 8, 2026 12:00 PM
